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The events that prime pluripotent cells for differenti-
ation are not well understood. Inhibitor of DNA
binding/differentiation (Id) proteins, which are inhibi-
tors of basic helix-loop-helix (bHLH) transcription
factor activity, contribute to pluripotency by blocking
sequential transitions toward differentiation. Using
yeast-two-hybrid screens, we have identified Id-
regulated transcription factors that are expressed
in embryonic stem cells (ESCs). One of these,
Tcf15, is also expressed in the embryonic day 4.5
embryo and is specifically associated with a novel
subpopulation of primed ESCs. An Id-resistant form
of Tcf15 rapidly downregulates Nanog and acceler-
ates somatic lineage commitment. We propose that
because Tcf15 can be held in an inactive state
through Id activity, it may prime pluripotent cells for
entry to somatic lineages upon downregulation of
Id. We also find that Tcf15 expression is dependent
on fibroblast growth factor (FGF) signaling, providing
an explanation for how FGF can prime for differenti-
ation without driving cells out of the pluripotent state.
INTRODUCTION
Considerable progress has been made in establishing the
factors that maintain pluripotency (Chambers and Smith,
2004). In contrast, little is known about the transcription factors
that guide the transition from pluripotency to somatic lineage
commitment. Pluripotent cells are maintained by a network of
pluripotency factors that include Oct4, Sox2, Nanog, Klf4, and
Esrrb. In the early blastocyst, fibroblast growth factor (FGF) 4
drives a subpopulation of cells toward a primitive endoderm
fate (Nichols et al., 2009; Yamanaka et al., 2010). Cells that
escape FGF action and retain high levels of Nanog go on to
become restricted to an epiblast fate by around embryonic day
4.25 (E4.25) (Nichols and Smith, 2009; Yamanaka et al., 2010).
Experiments using embryonic stem cells (ESCs) show that FGF
signaling is required not only for primitive endoderm differentia-
tion but also for competence to differentiate into somatic cell
types (Kunath et al., 2007). FGF is necessary but not sufficient
to drive lineage commitment: further progression to overt differ-
entiation is restrained by the combination of leukemia inhibitory
factor (LIF) and bone morphogenetic protein (BMP) signaling,
both of which restrict cells from progressing to a postimplanta-
tion epiblast-like state (Ying et al., 2003).
The transcription factors that act downstream of FGF in order
to drive epiblast cells toward this differentiation-primed state are
not known. A clue to their identity comes from the finding that
inhibitor of DNA binding/differentiation (Id) proteins are able to
block the transition of ESCs to epiblast stem cells (EpiSC) (Zhang
et al., 2010). Id proteins classically function through the inhibition
of active basic helix-loop-helix (bHLH) transcription factors. We
thus hypothesized that epiblast priming is driven by specific
bHLH factors that are expressed in pluripotent cells but held in
an inactive state through the action of Id proteins. As soon as
Id proteins are downregulated, the bHLH activity of these
‘‘primed’’ cells would be released from inhibition, allowing
epiblast maturation to proceed.
In other cell types, Id proteins act through either direct binding
and inhibition of bHLH transcription factors or indirect inhibition
of bHLH transcription factor function through binding and
sequestration of their essential heterodimerization partners E
proteins (including E47 and E12) (Norton, 2000). Thus, we set
out to identify the targets of Id inhibition by determining the direct
binding partners of both Id and E proteins in ESCs. To achieve
this, we performed a series of yeast two-hybrid (Y2H) screens
for binding partners of Id1, E47, and E12 within a library gener-
ated from the messenger RNA (mRNA) of pluripotent mouse
ESCs. This revealed three Id-regulated bHLH factors that are ex-
pressed in ESCs, of which one, Tcf15, is also expressed in the
inner cell mass of the E4.5 embryo.
Despite a known function in controlling somite development
(Burgess et al., 1996), a role for Tcf15 at this earlier development
stage has been unknown. Here, we demonstrate a distinct wave
of Tcf15 expression in the late preimplantation embryo in vivo
and a transient spike of expression during the early stages of
ESC differentiation in vitro. We show that an Id-resistant form
of Tcf15 rapidly downregulates Nanog and accelerates the tran-
sition of ESCs through the epiblast state while suppressing prim-
itive endoderm differentiation.
Efforts to understand the balance between pluripotency and
lineage commitment havebeen hampered by the lack of amarker
that can be used tomonitor exit from the pluripotent state toward
somatic lineages. Tcf15 acts as amarker of this transition state: it
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is rapidly upregulated as ESCs transit from a naive to a primed
state, and is associated with a subpopulation of epiblast-primed
Oct4+ Nanog/Klf4-low cells. Transcription of Tcf15 is driven by
FGF signaling, whereas its activity is suppressed by Id proteins,
which are direct targets of BMP signaling (Nakashima et al.,
2001; Ying et al., 2003; Wilson-Rawls et al., 2004); this helps
explain how these extrinsic signals allow pluripotent cells to
become primed for, but restrained from, somatic differentiation.
RESULTS
Identification of Id Protein Targets in ESCs through Y2H
Screening of an ES-Cell cDNA Library
Id1 is expressed in ESCs and can block the transition of ESCs to
differentiation-primed epiblast (Ying et al., 2003; Pollard et al.,
2006; Zhang et al., 2010). However, the transcription factor
targets of Id, and thus the mechanisms by which Id controls
these early transitions, remain unknown (Figure 1A). We used
a Y2H screening strategy to identify the direct binding partners
of Id and E proteins in ESCs. We constructed a random primed
complimentary DNA (cDNA) library of 2.6 3 106 independent
clones from themRNA extracted from a homogenousmonolayer
culture of self-renewing ESCs (maintained in media containing
LIF and fetal calf serum [FCS]). Y2H screens of this library were
performed for Id1, E47, and E12 baits using the highly stringent
Matchmaker (Clontech) system in which positive interactions
are dependent on the activation of three independent reporter
genes (Figure 1B).
Identification of E47/E12 as Binding Partners of Id1
We first screened for Id1 binding partners within our ES-cell
cDNA library. In total, 3.6 3 107 clones were screened. Of
1,133 positively interacting clones, the vast majority (1,091)
were found to correspond to coding sequences of the E2A
gene products E47 and E12. All putative Id1-interacting partners
were tested through a series of controlled Y2H reactions. E47
and E12 exhibited strong and specific interactions with Id1,
whereas all other candidates were ruled out owing to nonspecific
positive interactions or inability to bind Id1 (Figures 1C and 1E).
We conclude that the only true binding partners identified are
E47/E12. Id1 is therefore likely to function in ESCs through E
protein sequestration, with downstream bHLH targets consti-
tuting direct binding partners of E47/E12.
Identification of bHLH Factors Tcf15, Twist1, and
NeuroD1 as Binding Partners of E47/E12
We next screened for binding partners of E47 and E12; having
determined that the full-length proteins are toxic in yeast,
screens were performed using the bHLH domains of these
proteins (E47488-648 and E12488-651). Of 2.2 3 107 and 2.0 3
107 clones tested, 35 and 32 positive interacting clones were de-
tected as putative binding partners of E47 and E12, respectively.
Upon further testing, five factors were confirmed as true interact-
ing partners; the remainder were excluded owing to nonspecific
interactions or inability to bind E47/E12 (Figures 1C and 1E). Of
the five true interacting partners, two correspond to Id1 and
Id3, confirming the results of the Id1 screen; the remaining three
correspond to bHLH transcription factors Tcf15, Twist1, and
NeuroD1. These bHLH factors have recognized functions in
other cell types at later developmental stages and are known
targets of Id protein inhibition (Naya et al., 1995; Wilson-Rawls
et al., 2004; Connerney et al., 2006) but have no previously iden-
tified functions in ESCs or in the preimplantation embryo.
To ensure we had not missed any important binding partners,
we also performed an E12488-651 library screen using a reduced-
stringency method that is designed to favor the detection of
lower-affinity interactions (Figure 1B). Of 1.7 3 107 clones
screened, 127 positive interacting cloneswere detected. In addi-
tion to Id1, Id3, Tcf15, Twist1, and NeuroD1, we also confirmed
protein inhibitor of activated STAT factors Pias1, Pias2, and
Pias4, and homeodomain-interacting protein kinase Hipk2, as
true but weaker binding partners of E47 and E12 (Figures 1D
and 1E). Pias1 has already been reported as an E12 binding
partner (Kawai-Kowase et al., 2005), further validating our
screening strategy. However, no additional transcription factors
were identified from this lower-strategy screen. Our Y2H studies
therefore led to the identification of three bHLH transcription
factors as candidates for mediating the effect of Id in pluripotent
cells: Tcf15, Twist1, and NeuroD1.
Tcf15 Is Expressed in Pluripotent Populations
We next checked expression of the three candidates in preim-
plantation embryos. NeuroD1 expression was not detected in
the E4.5 blastocyst, and although we did detect Twist1 expres-
sion, it was at significantly lower levels than in ESCs. In contrast,
Tcf15 expression was readily detected in the E4.5 blastocyst at
levels comparable to those found in ESCs (Figure 2A).
Figure 1. A Y2H Screen to Identify Transcription Factors Regulated by Id1 in ES Cells
(A) FGF signaling primes pluripotent cells for differentiation. Id1 inhibits subsequent transitions: first to epiblast and then to neuroepithelium. We hypothesize that
unknown Id-regulated transcription factors are expressed in epiblast-primed cells.
(B) A Y2H library screen was performed by mating the Y187 yeast strain carrying the pGBKT7-bait vector (Id1, E47HLH, or E12HLH) with the AH109 yeast strain
carrying the pGADT7-library vector (mouse ESC cDNA library). For high-stringency selection, positive interactors were determined by growth of mated yeast on
SD/-Ade/-His/-Leu/-Trp media and positive X-Gal reaction (indicating activation of ADE2, HIS1 and LacZ reporter genes). For medium-stringency selection,
positive interactions were determined by initial growth of mated yeast on SD/-His/-Leu/-Trp media (indicating activation of HIS1 reporter gene), with subsequent
growth on SD/-Ade/-His/-Leu/-Trp media and positive X-Gal reaction (indicating activation of ADE2, HIS1 and LacZ reporter genes).
(C) High-stringency Y2H analysis of interactions among Id1, E47HLH, and E12HLH, and genes identified through library screens; positive interactors are determined
by growth on SD/-Ade/-His/-Leu/-Trp media and positive X-Gal reaction.
(D) Medium-stringency Y2H analysis of interactions among Id1, E47HLH, and E12HLH, and genes identified through library screens; positive interactions are
determined by initial growth on SD/-His/-Leu/-Trp media with subsequent growth on SD/-Ade/-His/-Leu/-Trp media and positive X-Gal reaction.
(E) The genes identified as pGADT7 vector inserts that interact with Id1, E47HLH, or E12HLH at the protein level within yeast are shown along with the number of
times clones were identified in each screen, and whether each gene was confirmed as a true binding partner of Id1 or E47/E12 by subsequent analysis. The total
numbers of noninteracting and autoactivating inserts identified are also shown.
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Expression dramatically declines postimplantation before rising
again at E8.5, in keeping with the previously reported expression
of Tcf15 in the developing somites (Burgess et al., 1995) (Fig-
ure 2A). Expression of Tcf15 prior to E7.5 has not been previously
reported in the literature, although the early wave of Tcf15
expression in the blastocyst is apparent in the Unigene EST
expression database. In situ hybridization confirmed that Tcf15
is expressed in the E4.5 blastocyst and revealed that it is specif-
ically detected in the inner cell mass (Figure 2B).
Upon directed differentiation of ESCs to either neural or non-
neural lineages, high Tcf15 expression persists after the marker
of naive pluripotency Rex1 is downregulated (Figures 2C and
2D). Tcf15 is downregulated at around the time that cells commit
to differentiation, as measured by the upregulation of overt
neural marker Sox1 (Wood and Episkopou, 1999) (Figure 2C).
Tcf15 protein is readily detectable within the nucleus of ESCs
but not in spontaneously differentiating cells within the same
culture or in cells that have been cultured for 4 days under differ-
entiation conditions (Figure 2E).
Tcf15 Marks a Population of Primed ESCs
Pluripotent cells can exist in a ‘‘naive’’ state, possibly represent-
ing cells from the early blastocyst or in a ‘‘differentiation primed
state’’ that may correspond to cells within the mature blastocyst
Figure 2. Tcf15 Is Expressed in Pluripotent
Cells
(A) qPCR analysis of Tcf15 expression in embryos
at different developmental ages. dec, decidual
tissue; ES, embryonic stem cells.
(B) In situ hybridization of an E4.5 mouse embryo
with a Tcf15 probe.
(C) qPCR analysis of ESCs undergoing differenti-
ation into the neural lineage in serum-free media.
(D) qPCR analysis of ESCs undergoing differenti-
ation into a mixture of predominantly nonneural
lineages in the presence of FCS and the absence
of LIF.
(E) Antibody staining for Tcf15 in ESCs cultures
containing a mixture of ESCs and spontaneously
differentiating cells or after 4 days differentiation in
serum-free media.
All data are represented as mean ±SD.
or the early postimplantation epiblast
(Nichols and Smith, 2009). Single-cell
quantitative PCR (qPCR) analysis has re-
vealed that Tcf15 is upregulated as ESCs
are derived from E3.5 blastocysts and
that Tcf15 is predominantly associated
with the Gata6-negative subpopulation
during the derivation process (Tang
et al., 2010). This suggests that Tcf15
may become specifically upregulated in
cells that are maturing into epiblast-
primed ESCs but not into primitive endo-
derm. Pharmacological inhibitors of Erk
and GSK3b can be used to maintain
ESCs in a naive state (Ying et al., 2008),
whereas culture in FGF2 plus activin drives them into differenti-
ation-primed EpiSC (Brons et al., 2007; Tesar et al., 2007).
Microarray analysis of the transition of naive ESCs to EpiSC
indicates that Tcf15 expression increases during the early transi-
tion period (Hayashi et al., 2011). Similarly, we find a strong
increase in Tcf15 expression as naive ESCs move into a primed
ES-cell state (Figure 3A) and an early transient pulse of Tcf15
expression as naive ESCs move toward neural differentiation
(Figure 3B).
Tcf15 shares an almost identical DNA binding domain with the
closely related bHLH transcription factor Scleraxis (Scx)
(Burgess et al., 1995). Although Scx did not emerge from our
screen (Figure 1), we considered the possibility that it could act
as an early prodifferentiation factor in ESCs. We found, however,
that Scx is not consistently detectable by qPCR in ESCs main-
tained in LIF + FCS (data not shown) although it does become
upregulated in EpiSC (Figure S1), in keeping with its reported
expression in the postimplantation epiblast (Brown et al.,
1999). Because Scx is not expressed in ESCs, we eliminated it
as a candidate determinant of early primed pluripotent state.
ESCs cultured in LIF + FCS are heterogeneous mixtures of
primed cells and naive cells (Nichols and Smith, 2009), with naive
cells marked by Klf4 and Nanog. In order to find out whether
Tcf15 is associated with the primed state in these mixed
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cultures, we made use of a sensitive reporting strategy for Tcf15
based on translational amplification of a fluorescent protein. The
216D1 Tcf15 reporter cell line was generated by gene trapping:
a gtx-IRES-Venus cassette was incorporated into the 30 UTR
of Tcf15 (Tanaka et al., 2008). Venus shows a heterogeneous
distribution within ESC cultures (Figure 3C) and becomes unde-
tectable in the majority of cells after differentiation, in keeping
with the downregulation of Tcf15 upon differentiation (Figures
2C and 2D).
We plated Tcf15-Venus reporter cells at clonal density and
allowed colonies to form over 5 days. Many colonies were
morphologically undifferentiated yet were mosaic for Venus
expression, supporting the idea that Tcf15 may be associated
with a dynamic subpopulation of ESCs (Figure 3D).
Both the Venus-high subpopulation and the Venus-low
subpopulations within these colonies of ESCs express Oct4,
whereas Nanog and Klf4 were predominantly expressed only
Figure 3. Tcf15 Marks a Subpopulation of
Differentiation-Primed ES Cells
(A) qPCR analysis of puro-selected Oct4GIP cells
after at least 1 week of culture in 2i, LIF + BMP, or
EpiSC conditions.
(B) qPCR analysis of ESCs undergoing neural
differentiation starting from 2i conditions.
(C) Antibody staining for E-cadherin (Cdh1) in
a population of Tcf15-Venus reporter ESCs in
LIF + FCS.
(D) Tcf15-gtxIRES-Venus reporter cells stained for
Nanog, Klf4, or Oct4.
(E) Quantitative immunofluorescence analysis of
Tcf15-gtxIRES-Venus reporter cells stained for
Nanog, Klf4, or Oct4.
(F) Proportion of cells positive for Tcf15-Venus
only (green) or Nanog/Klf4/Oct4 (red) or both.
(G) qPCR analysis of subpopulations of ESCs
gated for PECAM+ and sorted on the basis of
Tcf15-Venus expression.
(H) Western blot for Nanog in subpopulations of
ESCs gated for PECAM+ and sorted on the basis
of Tcf15-Venus expression.
(I) qPCR analysis of subpopulations of ESCs gated
for PECAM+ and sorted on the basis of Tcf15-
Venus expression.
All data are represented as mean ±SD. See also
Figure S1.
within the Venus-low subpopulation (Fig-
ure 3D). We used quantitative immunoflu-
orescence in order to further examine the
relationship between Tcf15-Venus and
Nanog, Klf4, or Oct4 in ESCs (Figures
3E and 3F). This confirmed that less
than 15% of Venus-high cells express
Nanog or Klf4 whereas over 95% express
Oct4 (Figure 3F). This indicates that Tcf15
marks an undifferentiated but differentia-
tion-primed state.
We confirmed that Venus correlates
with Tcf15 mRNA in subpopulations of
Venus-high and Venus-low ESCs sorted
by flow cytometry (Figure 3G). In keeping with our quantitative
immunofluorescence analysis, we found transcripts for naive
pluripotency markers to be enriched in the Venus-low sub-
population of ESCs (Figure 3G). Nanog protein was also enriched
in the Venus-low subpopulation (Figure 3H). These data suggest
that Tcf15 marks an undifferentiated but differentiation-primed
state.
Hex has been reported to mark a subpopulation of ESCs
that are primed for primitive endoderm (Canham et al., 2010);
however, microarray analysis of Hex-high and Hex-low sub-
populations indicates that Tcf15 is not specifically associated
with theHex-high population (Canhamet al., 2010). Furthermore,
we find that Hex is not associated with the Tcf15-high population
(Figure 3I). Taken together, these data suggest that Tcf15 is
associated with a differentiation-primed state that differs
from the previously described primitive endoderm-primed
subpopulation.
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Tcf15 Accelerates Differentiation
We next tested whether Tcf15 has prodifferentiation activity in
ESCs.Weengineered a formof Tcf15 that is tethered by a flexible
linker to its heterodimerization partner E47 (Figure S2A). This
strategy renders Tcf15more resistant to inhibition by Id (Neuhold
andWold, 1993) andalso avoidsdisrupting thebalanceof endog-
enous bHLH factors in the cell. This construct was placed under
the control of a tetracycline (tet)-responsive promoter and
integrated into a cell line that constitutively expresses a reverse
tetracycline-controlled transactivator (rtTA) from the Rosa26
(R26) locus (FigureS2B). This allowedTcf15 tobeartificiallymain-
tained under differentiation conditions at levels similar to those in
ESCs (Figure S3C), with expression being lost within 24 hr of
removing doxycycline (dox) (Figure S3D). Using this system, we
find that Tcf15 accelerates neural differentiation: Tuj1+ neurites
were abundant by the third day in dox-treated but not control
cultures (Figure 4A). Tcf15-E47 is effective at accelerating differ-
entiation even if expressed only during the first 24 hr of differen-
tiation (Figures 4A and 4B). This suggests that Tcf15 activity
may be a limiting factor at an early stage of neural induction.
The ability of Tcf15 to accelerate differentiation was not
restricted to the neural lineage. LIF withdrawal in the presence
of FCS causes ESCs to differentiate into a mixture of different
nonneural cell types; under this protocol, differentiation was
also accelerated (Figure S3) without promoting neural differenti-
ation (data not shown). Furthermore, somatic lineage choice did
not appear to be biased significantly by Tcf15 as measured by
the dose-dependent ability of BMP to suppress neural differen-
tiation (marked by Sox1) and instead promote nonneural differ-
entiation (marked by Brachyury) (Figure 4C). Tcf15 therefore
does not appear to mediate the ability of BMP/Id to suppress
neural induction (Ying et al., 2003) but may mediate the earlier
role of Id to inhibit the transition of ESCs to differentiation-primed
epiblast (Zhang et al., 2010) (see these two transitions illustrated
in Figure 4D).
Tcf15 Drives the Transition to Epiblast and Suppresses
Primitive Endoderm Differentiation
ESCs cultured in LIF + FCS or LIF + BMP are restrained from pro-
gressing to overt differentiation but free to explore naive and
primed states of pluripotency (Nichols and Smith, 2009). We
used these conditions to ask whether Tcf15-E47 can drive the
transition to a primed state. Under these conditions, Tcf15-E47
is able to downregulate markers of naive ESCs and upregulate
the epiblast marker Fgf5 (Figure 5A). A 24 hr pulse of dox drives
irreversible commitment to differentiation in a significant propor-
tion of cells even in the continued presence of LIF + BMP (Fig-
ure 4B). These cells were morphologically similar to cells from
which LIF has been withdrawn. This suggests that Tcf15-E47
may drive the loss of LIF responsiveness, which is a character-
istic feature of the transition toward postimplantation EpiSC
(Brons et al., 2007; Tesar et al., 2007). We confirmed that
Tcf15 alone, but not E47 alone, recapitulates the ability of
Tcf15-E47 to favor differentiation (Figure S4), in keeping with
reports that E47 cannot act as a transcription factor in its own
right in most cell types, with the single exception of B cells. (Ben-
ezra, 1994; Shen and Kadesch, 1995; Sloan et al., 1996; Markus
and Benezra, 1999).
We next asked whether Tcf15-E47 primes ESCs for differenti-
ation into extraembryonic endoderm as well as into epiblast-
derived somatic cell types. Upon removal of LIF and BMP,
a subpopulation of ESCs spontaneously differentiate into primi-
tive endoderm as determined both by their characteristic mor-
phology and upregulation of the extraembryonic endoderm
marker Sox7: both indicators of primitive endoderm differentia-
tion were almost completely eliminated upon induction of
Tcf15-E47 (Figures 5C and 5D). We confirmed that Tcf15-E47
accelerates upregulation of epiblast marker FGF5 and sup-
presses expression of primitive endoderm marker Sox7 when
ESCs are placed in N2B27 + basic FGF + activin, conditions
that favor conversion of ESCs into EpiSC (Tesar et al., 2007).
We conclude that Tcf15 primes pluripotent cells for the transi-
tion tomature differentiation-primed epiblast but not for differen-
tiation into extraembryonic endoderm. Consistent with this idea,
Id1 gene expression is high in the primitive endoderm (Canham
et al., 2010), suggesting that Tcf15 activity is usually suppressed
in this cell type.
Tcf15 Expression Is Dependent on FGF Signaling
Tcf15 is able to prime cells for differentiation by driving the tran-
sition to a mature epiblast-like state; because Tcf15 is an Id-
regulated factor, this explains why Id is able to suppress the
conversion of ESCs into EpiSC (Zhang et al., 2010). We
show above that Tcf15 is expressed specifically in cells that
are primed for differentiation. We next investigated the mecha-
nism by which Tcf15 expression becomes associated with this
primed state.
We used Tcf15-Venus reporter cells to investigate which of the
components of 2i culture is responsible for suppressing Tcf15
expression. We first confirmed that Venus expression is unde-
tectable in 2i conditions and expressed in a subset of cells in
LIF + FCS (Figure 6A). Transfer to basal media (N2B27) or basal
media with Chiron alone did not have any obvious impact on
Venus expression, but PD0325901 reduced Venus to almost
undetectable levels (Figure 6A). We conclude that Erk signaling
is required for maintaining Tcf15 expression in ESCs. We
confirmed that endogenous Tcf15 protein was also lost when
cells were cultured in the presence of PD0325901 but main-
tained when cells were cultured in the presence of Chiron (Fig-
ure 6B). Fibroblast growth factor receptor (FGFR) inhibitor
PD17 was also able to suppress Tcf15 expression (Figure 6C).
The response of Tcf15 to FGF is rapid: Tcf15 is strongly upregu-
latedwithin 6 hr of removing FGFR or Erk inhibitors.We conclude
that Tcf15 expression is dependent on autoinductive FGF
signaling and that it responds rapidly to increases in FGF activity
(Figure 6D). FGF could therefore prime cells for differentiation by
upregulating the prodifferentiation factor Tcf15 (Figure 6E),
whereas BMP/Idmay restrain progression to overt differentiation
from this primed state by inhibiting Tcf15 activity.
Tcf15 Downregulates the Pluripotency Determinant
Nanog and Upregulates the Epiblast Determinant Otx2
We next set out to ask how Tcf15 drives pluripotent cells away
from naive pluripotency and toward epiblast. We carried out
a time-coursemicroarray analysis aimed at capturing the earliest
changes in gene expression in response to Tcf15. Using our
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dox-inducible Tcf15-E47 ESC lines, we found that Tcf15-E47
protein becomes weakly detectable at around 8 hr after addition
of dox and reaches robust levels after 12 hr (Figure 7A). A total of
only 61 genes changed significantly over these two early time
points. Of these, the most strongly downregulated gene at both
time points is Nanog (Figures 7B–7D). This further validates our
hypothesis that Tcf15 activation represents the first step toward
differentiation and suggests amechanism bywhich it drives cells
away from a naive pluripotent state. Furthermore, the epiblast-
determinant Otx2 (Acampora et al., 2012) was one of the top-
ten most significantly upregulated genes at early time points
(Figures 7B–7D), explaining how Tcf15 specifically favors
epiblast rather than primitive endoderm differentiation after loss
of Nanog. We confirmed that a burst of Tcf15 expression
Figure 4. Tcf15 Accelerates Differentiation
(A) Tuj1 staining to detect neurons during neural differentiation of dox-inducible Tcf15-E47 ESCs.
(B) qPCR analysis of dox-inducible Tcf15-E47 ESCs undergoing neural differentiation.
(C) qPCR analysis of dox-inducible Tcf15-E47 ESCs after 4 days in N2B27 in the presence of various doses of BMP4.
(D) BMP/Id suppresses the transition of ESCs to EpiSC and then the transition of EpiSC toward neural progenitors.
All data are represented as mean ±SD. See also Figure S2.
Cell Reports 3, 1–13, February 21, 2013 ª2013 The Authors 7
Please cite this article in press as: Davies et al., Tcf15 Primes Pluripotent Cells for Differentiation, Cell Reports (2013), http://dx.doi.org/10.1016/j.cel-
rep.2013.01.017
accompanies the loss of Nanog and precedes the upregulation
of Otx2 during the transition of ESCs to EpiSC (Figure 7E).
Thesedata support amodel inwhichTcf15drivesESCsout of a
naive pluripotent state by suppressing expression of Nanog and
toward a mature epiblast state by upregulating Otx2 (Figure 7F).
DISCUSSION
Pluripotent cells navigate a route toward lineage commitment
through a complex network of positive and negative cues. The
negative cues that restrain cells in a pluripotent state include
transcription factors Nanog and Klf4 and signaling pathways
activated by BMP and LIF. In contrast, little is known about the
positive cues that drive progression toward lineage commit-
ment. The transition from naive epiblast to mature differentia-
tion-primed epiblast spans the peri-implantation period and is
therefore technically challenging to study in vivo. Conversion of
ESCs to EpiSC in culture recapitulates the progression from
naive preimplantation epiblast to epithelialized egg cylinder
in vivo (Rossant and Tam, 2009) and provides a useful tool for
Figure 5. Tcf15 Drives the Transition to Primed Epiblast and Suppresses Primitive Endoderm Differentiation
(A) qPCR analysis of dox-inducible Tcf15-E47 ESCs after 4 days in N2B27 + LIF + BMP4.
(B) Dox-inducible Tcf15-E47 ESCs after 4 days in N2B27 + LIF + BMP4. Second panel shows cells that received a 24 hr pulse of dox during the first day.
(C) Dox-inducible Tcf15-E47 ESCs after 4 days in N2B27. Treatment with dox eliminates spontaneous differentiation into primitive-endoderm-like cells.
(D) qPCR analysis of dox-inducible Tcf15-E47 cells during differentiation in N2B27.
(E) qPCR analysis of dox-inducible Tcf15-E47 cells after transfer to EpiSC conditions.
All data are represented as mean ±SD. See also Figures S3 and S4.
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interrogating this process. This system has identified Id1 as a key
negative regulator of the transition of ESCs to EpiSC (Zhang
et al., 2010) implicating unknown bHLH transcription factors in
priming pluripotent cells for differentiation.
We have used a Y2H screening strategy to identify prodifferen-
tiation factors that are likely to be regulated by Id1 in ESCs.
Searching within an ESC cDNA library, the only proteins that
we found to directly bind to Id1 were the E proteins E12 and
E47. Although it does remains possible that there may be direct
binding partners of Id1 in ESCs that were not picked up in our
screen, we conclude that Id1 is likely to be acting at least in
Figure 6. Tcf15 Is Regulated by FGF
Signaling
(A) Tcf15-Venus cells cultured for 6 days in N2B27
under the stated conditions.
(B) Western blot analysis of E14tg2a cells cultured
for 6 days in N2B27 under the stated conditions.
(C) qPCR analysis of E14tg2a cells treated for 48 hr
with the FGFR inhibitor PD17.
(D) qPCR analysis of E14tg2a cells in N2B27 +
LIF + BMP treated for 48 hr with the FGFR inhibitor
PD17 or the ERK inhibitor PD0325901 or 6 hr after
washout of inhibitors.
(E) FGF upregulates Tcf15 expression and drives
the transition to epiblast.
All data are represented as mean ±SD.
part through sequestration of these two
E proteins. Regulators of ESC differentia-
tion are therefore likely to include direct
binding partners of these E proteins.
We have identified one such factor,
Tcf15, as a bHLH transcription factor
that is expressed in the late preimplanta-
tion embryo and within a differentiation-
primed subpopulation of ESCs, and
which can accelerate differentiation
when rendered immune to Id inhibition.
What relevancemight our findings have
for the development of the epiblast
in vivo? Tcf15 is best known as a regulator
of somite development (Burgess et al.,
1996), and there are some intriguing
parallels between somitogenesis and
epiblast formation. In somites, Tcf15 is
not required for cell fate specification;
rather, Tcf15 is necessary and sufficient
for remodeling of mesenchyme into an
N-cadherin+ polarized epithelial structure
(Burgess et al., 1996; Linker et al., 2005;
Takahashi et al., 2005). Epithelialization
in the somites is a consequence of N-
cadherin-mediated cell-cell adhesion
(Duband et al., 1987). Transition of the
inner cell mass of the blastocyst under-
goes a similar remodeling process as it
matures into postimplantation epiblast,
including the upregulation of N-cadherin
(Hatta et al., 1987; Bao et al., 2009) and formation of a polarized
N-cadherin E-cadherin double-positive epithelium. We specu-
late that Tcf15 may therefore play a similar role in both scenarios
to help trigger the morphological remodeling events that charac-
terize these changes in cell identity.
Tcf15 mutant embryos survive to birth, but die shortly after-
ward as a consequence of muscular-skeletal defects due to
the failure in somite morphogenesis earlier in development. We
speculate that by analogy with its role in the somites and based
on our own ESCdata, Tcf15may perhaps also help to coordinate
epithelialization of the epiblast. The consequence of removing
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this earlier function of Tcf15 could be to delay epiblast formation
and consequently to disrupt the kinetics of subsequent lineage
allocation. However, the early embryo is highly regulative, and
such phenotypes may therefore not be readily apparent when
examining mutant embryos at late stages. Indeed, a phenotype
may only manifest itself as a lowering of the robustness of the
early developmental process, which may only become apparent
under suboptimal conditions. Furthermore, any putative Tcf15
mutant phenotype may be masked by compensatory premature
upregulation of the closely related transcription factor Scx,
which shares an almost identical DNA binding domain with
Tcf15 (Burgess et al., 1995). Scx has an established role in later
stages of epiblast maturation: from around E6.5 the epiblast of
Scx mutants fails to develop further and does not properly
Figure 7. Tcf15 Downregulates Nanog and
Upregulates Otx2
(A) Western blot analysis of flag-Tcf15-E47 or
parental cells in ESCs at various time points after
addition of dox.
(B) Genes that respond most strongly to Tcf15-
E47 after 12 hr dox treatment. Note that Tcf3 refers
to the E2A gene and detects the E47 transgene in
this experiment.
(C) Fold change in all genes within the microarray
probe set. Nanog is highlighted in red and Otx2 is
highlighted in green.
(D) qPCR validation showing downregulation of
Nanog pre-mRNA and Otx2 mRNA in response to
dox-mediated induction of Tcf15-E47 in ESCs.
(E) qPCR analysis showing the kinetics of Tcf15,
Nanog, and Otx2 expression during the transition
toward EpiSC.
(F) Model. We propose that Tcf15 suppresses
Nanog and activatesOtx2 to drive pluripotent cells
away from naive pluripotency and toward epiblast.
All data are represented as mean ±SD.
epithelialize. Intriguingly, the Scx mutant
phenotype begins to manifest itself
shortly after Tcf15 is downregulated
after implantation (Brown et al., 1999),
supporting the idea that these two tran-
scription factors act sequentially during
development andmay exhibit some func-
tional redundancy. However, Scx is not
expressed in ESCs and therefore, unlike
Tcf15, does not mark an early epiblast-
primed pluripotent state. It will be of
interest in future studies to explore the
relevance of our ES-based studies for
early embryonic development.
Even in the continued presence of LIF,
a subset of ESCs downregulate markers
of naive pluripotency. This subset of
ESCs is consequently primed toward
differentiation (Chambers et al., 2007;
Toyooka et al., 2008; Kalmar et al.,
2009). Recent work shows that some of
these Nanog-low cells, marked by the
endodermal transcription factor Hex, are primed for primitive
endoderm, but a third population expresses neither Hex nor
naive pluripotency markers (Canham et al., 2010). It has been
speculated (Canham et al., 2010; Lanner and Rossant, 2010)
that this third population is primed for differentiation into mature
epiblast and therefore ultimately for differentiation into somatic
cell types, but a marker of this early primed state has proved
elusive. We find that Tcf15-Venus marks a Klf4-low Nanog-low
subpopulation but is not specifically associated with Hex. Taken
together with the ability of Tcf15 to drive epiblast priming, this
indicates that Tcf15 marks the epiblast-primed subpopulation
of ESCs and identifies cells taking the first step toward embryonic
rather than extraembryonic lineages. In support of this idea,
our genome-wide analysis reveals Nanog to be the gene most
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rapidly downregulated in response to Tcf15 and the epiblast-
determinant Otx2 to be one of the genes most rapidly upregu-
lated in response to Tcf15. This further validates our hypothesis
that Tcf15 activation represents the first step toward differentia-
tion of ESCs, and suggests a mechanism by which it acts.
How does FGF prime cells for differentiation without pushing
them out of the pluripotent state? Tcf15 is a prodifferentiation
factor whose expression is driven by the priming factor FGF
but whose activity is likely to be restrained by the antidifferentia-
tion factor BMP4 through upregulation of Id. Although other
targets of FGF and Id are likely to cooperate with Tcf15 to prime
pluripotent cells for differentiation, our work provides one clear
example of how this priming mechanism operates. FGF/Erk
activity is required for somatic commitment from ESCs (Kunath
et al., 2007). However, it is not clear how much Erk activity there
is in late preimplantation or peri-implantation epiblast: certainly
activity is not as high as in extraembryonic tissues at these
stages (Corson et al., 2003). Any ERK signaling within the
epiblast is therefore likely to be relatively transient. It is inter-
esting in this respect that Tcf15 expression is also transient in
the early embryo: it is readily detectable at E4.5 but returns to
background levels by E5.5. In contrast, the widely used epiblast
marker T-Brachyury (Lanner and Rossant, 2010) is expressed
later than Tcf15 and persists as cells exit the epiblast and commit
to mesodermal lineages. Tcf15 is a transcription factor that
specifically marks a transient FGF-primed intermediate on the
route from pluripotency toward somatic differentiation of ESCs.
In summary, we have used a Y2H screen to identify a marker,
Tcf15, of a transient cell state that stands midway between naive
pluripotency and somatic lineage commitment. We propose that
Tcf15 contributes toward steering pluripotent cells in the direc-
tion of somatic lineages and that it will serve as a valuable tool
for monitoring and interrogating early developmental transitions.
EXPERIMENTAL PROCEDURES
Y2H Analysis
The DNA sequences corresponding to mouse Id1 (1–176) and the HLH regions
of E47 (E47HLH: 488–648) and E12 (E12HLH: 488–651) were cloned into the Y2H
vectors pGBKT7 and pGADT7 (Clontech). Y2H analysis was performed using
the Matchmaker 3 Y2H system (Clontech), with protocols based on the manu-
facturer’s instructions. pGBKT7 and pGADT7 vectors were transformed into
the yeast strains Y187 and AH109, respectively, through a polyethylene
glycol/single-stranded DNA/lithium acetate procedure. Interactions between
bait and target proteins were tested by mating the Y187[pGBKT7-bait] strain
with the AH109[pGADT7-target] strain; single colonies from each strain were
resuspended in 0.5 ml 2xYPDA and incubated at 30C, 50 rpm for 24 hr.
Cultures were then diluted 1 in 10 using 0.5xYPDA, and 100 ml was plated
onto SD/Leu/Trp (double dropout) to select for mated colonies, and onto
SD/Ade/His/Leu/Trp (quadruple dropout) to select for mated colonies
with the activation of ADE and HIS reporter genes. Plates were incubated at
30C for 5 days. Colonies were lifted onto filters (Whatman No. 5, 70 mm),
lysed by two cycles of freeze-thaw at 80C, and b-galactosidase assays
were performed by incubation in 100 mM sodium phosphate (pH 7.0),
10 mM KCl, 1 mM MgSO4, 0.3% b-mercaptoethanol, 1 mg/ml X-Gal
(Promega) at 30C for 5 hr. All filter lift assays shown are representative of at
least three replicates performed using independent yeast transformants.
ES Cell cDNA Y2H Library Construction
A mouse ESC cDNA library was generated using the Matchmaker library
construction and screening kit (Clontech). Total RNA was extracted from
a homogenous monolayer culture of self-renewing mouse ESCs (E14Tg2a
strain) using an Absolutely RNA miniprep kit (Stratagene), and purified for
poly(A)+ RNA using anOligotexmRNAmini kit (QIAGEN). cDNAwas generated
by first strand synthesis using Moloney murine leukemia virus reverse tran-
scriptase with a random primer that inserts a 30 CDS III sequence; a 50 SMART
III sequence was then inserted and amplification performed by long-distance
PCR using Advantage 3 DNA polymerase (Clontech). cDNA was recombined
into the pGADT7 vector through cotransformation of the AH109 yeast strain
with cDNA and linearized vector using a high-efficiency polyethylene glycol/
single-stranded DNA/lithium acetate procedure; transformants were selected
on SD/-Leu plates. The resulting 2.6 3 106 colonies were pooled in 1l of
YPDA media supplemented with 10% glycerol, and frozen in 1 ml aliquots.
Y2H Library Screening
To perform a library screen, a Y187[pGBKT7-bait] strain was mixed with an
AH109[pGADT7-library] aliquot in 50 ml 2xYPDA and incubated at 30C,
50 rpm for 24 hr. For high-stringency screening, cultures were plated on
SD/Ade/His/Leu/Trp and incubated at 30C for 7 days; colonies
were subsequently grown three times on SD/Ade/His/Leu/Trp. For
medium-stringency screens, cultures were initially plated on SD/-His/-Leu/-
Trp and incubated at 30C for 7 days; colonies were then grown three times
on SD/Ade/His/Leu/Trp. The cDNA identities of positively interacting
pGADT7 vectors were determined through single-colony PCR with gel purifi-
cation and DNA sequencing. Vectors were extracted from positive colonies
using Zymoprep yeast plasmid miniprep kit II (Zymo Research), with pGADT7
vectors selected and amplified through ampicillin resistance in bacteria. Inter-
actions were then confirmed through the transformation of fresh AH109 yeast
with sequence-verified pGADT7 vectors, and with mating and b-galactosidase
assays performed as described above.
Mouse ES Cell Culture and Differentiation
ESCs were maintained as previously described (Smith, 1991). Neural differen-
tiation was carried out as previously described (Pollard et al., 2006).
Pharmacological Inhibitors
PD0325901 (used at 1 mM) and PD173074 (used at 100 ng/ml) were obtained
from Axon Medchem.
Western Blot Analysis
Blots were probed using conjugated anti-FLAG M2 peroxidase antibody
(1:1,000; A8592, Sigma), and monoclonal mouse anti-b-tubulin primary
antibody (1:4,000; T5293, Sigma) with monoclonal anti-mouse horseradish
peroxidase secondary antibody (1:3,000; Promega).
Immunofluorescence and FACS
Primary antibodies were obtained from the following sources Oct4 (Santa
Cruz: sc-5279); green florescent protein (Molecular Probes); Nestin (DSHB);
Sox2 (Chemicon); Neuronal beta-III tubulin (Covance); Nanog (gift of I.
Chambers); Tcf15 (Aviva).
Fluorescence-activated cell sorting (FACS) analysis was performed using
a Becton Dickinson FACS Calibur flow cytometer. FACS was carried out on
a Becton Dickinson FACS Aria flow cytometer. For sorting of Tcf15-Venus
cells, the top 30% of Venus+ cells and the bottom 30% of Venus-low
cells were sorted from within a platelet endothelial cell adhesion molecule
(PECAM)+ gated population, excluding differentiated cells.
Quantification of Nuclear Immunostaining
In order to quantify the fluorescence signal in each individual cell, we gener-
ated an automated pipeline for image analysis, described in full in Extended
Experimental Procedures.
In Situ Hybridization
Whole-mount in situ hybridization on MF1 3 MF1 mouse blastocysts was
performed according to the protocol of Rosen and Beddington (1993).
Digoxigenin-labeled anti-Tcf15 riboprobes were synthesized from Tcf15
cDNA clones (Burgess et al., 1995).
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Dox-Inducible Tcf15-E47 Cell Line
The DNA sequence corresponding to N-terminally FLAG-tagged mouse Tcf15
tethered at its C terminus to the N terminus of mouse E47 through a 13-amino-
acid flexible linker of sequence TGSTGSKTGSTGS was generated by overlap-
ping extension PCR. This sequence was placed under a tet-responsive
promoter and transfected into the E14tg2A_AW2 cell line, which contains
the coding sequence for the rtTA integrated into the Rosa 26 and expressed
from the R26 promoter. The E14tg2A_AW2 cell line will be described in more
detail elsewhere (A.W., S.L., and A.J.H.S., unpublished data).
Microarray Analysis
TTE15 and parental AW2 cells were plated in six-well plates (IWAKI) 1 day
before stimulation. Cells were stimulated by 1 mg/ml doxycycline for the
indicated time and lysed for RNA. Sample preparation and data analysis are
described in Extended Experimental Procedures.
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GSE42539.
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